Compare PED & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PED | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.8M | 165.6M |
| IPO Year | 2012 | 2020 |
| Metric | PED | QSI |
|---|---|---|
| Price | $13.43 | $0.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $30.00 | $1.00 |
| AVG Volume (30 Days) | 28.9K | ★ 1.6M |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $45,751,000.00 | $2,436,000.00 |
| Revenue This Year | $171.75 | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.67 | N/A |
| 52 Week Low | $0.43 | $0.69 |
| 52 Week High | $18.89 | $3.10 |
| Indicator | PED | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 47.93 |
| Support Level | $12.89 | $0.70 |
| Resistance Level | $13.92 | $0.79 |
| Average True Range (ATR) | 1.11 | 0.03 |
| MACD | -0.25 | 0.00 |
| Stochastic Oscillator | 11.28 | 44.17 |
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties with a long production history, well-defined geology, and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming, the Powder River Basin (PRB) in Wyoming, and the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin).
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.